Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
ExcellGene SA logo — We are a CDMO providing Swiss quality cell line development...

ExcellGene SA

We are a CDMO providing Swiss quality cell line development and protein expression services. Expect Great Science.

Founded 2001 Switzerland Monthey, Switzerland 66 employees Unknown Biotechnology, Information Technology

General Information

Company Name ExcellGene SA
Founded Year 2001
Location Switzerland Monthey, Switzerland +1
Employees 66
Industries Biotechnology, Information Technology
Funding Stage Unknown
Social

Get notified when ExcellGene SA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ExcellGene SA

ExcellGene SA is a Swiss CDMO (Contract Development and Manufacturing Organization) renowned for its superior cell line development and protein expression services. Established in 2001, the company has over two decades of expertise in biotechnology and information technology sectors.

Specializing in CHO and HEK293 cell lines, ExcellGene offers high-yielding solutions ready for GMP production, pivotal for biologics, biosimilars, and gene therapies. The company demonstrates a versatile capability to express a variety of proteins, including bi-specific monoclonal antibodies, Fc-fusions, and viral proteins, ensuring comprehensive support from process development through to master cell banking.

Located in Switzerland, the firm emphasizes a commitment to quality and customer satisfaction. Recently, ExcellGene garnered attention with a buyout investment from ArchiMed dated 01 September 2025, reflecting strong investor confidence and growth potential within the biotech landscape.

Taxonomy: CDMO, Cell Line Development, Protein Expression Services, Biologics Production, Biosimilars, Gene Therapy, CHO Cell Lines, HEK293 Cell Lines, AAV Production, Master Cell Banking, GMP Compliance, Scale-Up Processes, Process Development, Stable Protein Expression, Transient Protein Expression

Services & Products

CHO and HEK293 cell line development
Recombinant biologics manufacturing
Process development for upstream and downstream
Comprehensive cell banking services
Biosimilar cell line and process development

Target Customers

Biotechnology companies Pharmaceutical companies Biopharmaceutical research organizations

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Buyout Unknown 1
ArchiMed
01 Sep 2025
Spinout Unknown 1 EPFL Swiss Federal Institute of Technology in Lausanne 01 Oct 2001

ExcellGene SA Alternatives & Competitors

ExcellGene SA vs
UGA Biopharma GmbH
UGA Biopharma GmbH Germany

Your vision is our mission

25 employees
ExcellGene SA vs
trenzyme GmbH
trenzyme GmbH Germany

As full service provider for the life science industry, we have a clear mission: Accelerating your i...

22 employees
Biotechnology, Life Sciences
Compare ExcellGene SA vs trenzyme GmbH
ExcellGene SA vs
Celltheon Corporation
Celltheon Corporation United States

Global leader in Cell Line Development for Next Generation Bio-therapeutics

Series Unknown
16 employees
Biotechnology
Compare ExcellGene SA vs Celltheon Corporation
Also compare with: ExcellGene SA vs Cytovance Biologics Cytovance Biologics

FAQ About ExcellGene SA

We are a CDMO providing Swiss quality cell line development and protein expression services. Expect Great Science.
ExcellGene SA was founded in 2001.
ExcellGene SA is headquartered in Monthey, Switzerland.
ExcellGene SA operates in the following industries: Biotechnology, Information Technology.
ExcellGene SA has approximately 66 employees.
ExcellGene SA has completed 2 funding rounds. The latest funding stage is Unknown.
ExcellGene SA offers: CHO and HEK293 cell line development, Recombinant biologics manufacturing, Process development for upstream and downstream, Comprehensive cell banking services, Biosimilar cell line and process development.
Top alternatives and competitors to ExcellGene SA include UGA Biopharma GmbH, trenzyme GmbH, Celltheon Corporation, ProBioGen AG, inscreenex GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ExcellGene SA and UGA Biopharma GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ExcellGene SA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy